BASKET-PROVE II: BP-DES Noninferior to DP-DES

Article Figures & Data

Figures

  • Figure 1.

    Primary End Point Between Drug-Eluting Stents

    BMS, bare metal stent; BP-DES, biodegradable-polymer drug-eluting stent; DP-DES, durable-polymer drug-eluting stent.Adapted from Kaiser C et al. Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents Main Results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), A Randomized, Controlled Noninferiority 2-Year Outcome Trial. Circulation. E-pub ahead of print. DOI: 10.1161/CIRCULATIONAHA.114.013520. Accessed December 10, 2014. With permission from American Heart Association, Inc.
  • Figure 2.

    Key Safety Secondary End Point Between BP-DES and BMS

    BMS, bare metal stent; BP-DES, biodegradable-polymer drug-eluting stent; DP-DES, durable-polymer drug-eluting stent.Adapted from Kaiser C et al. Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents Main Results of the Basel Stent Kosten-Effektivitäts Trial- PROspective Validation Examination II (BASKET-PROVE II), A Randomized, Controlled Noninferiority 2-Year Outcome Trial. Circulation. E-pub ahead of print. DOI: 10.1161/CIRCULATIONAHA.114.013520. Accessed December 10, 2014. With permission from American Heart Association, Inc.